HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregory A Otterson Selected Research

Sunitinib (Sutent)

5/2015Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
2/2014CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregory A Otterson Research Topics

Disease

65Neoplasms (Cancer)
01/2022 - 06/2002
46Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2003
22Lung Neoplasms (Lung Cancer)
01/2022 - 04/2003
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 03/2010
6Neutropenia
10/2016 - 04/2006
6Leukemia
05/2015 - 05/2004
5Diarrhea
10/2019 - 06/2002
5Fatigue
10/2016 - 04/2006
4Thrombocytopenia (Thrombopenia)
10/2016 - 09/2004
3Neoplasm Metastasis (Metastasis)
01/2021 - 01/2013
3Adenocarcinoma
01/2018 - 01/2015
3Nausea
03/2016 - 11/2010
3Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 06/2002
3Malignant Mesothelioma
06/2012 - 05/2004
2Exanthema (Rash)
01/2022 - 11/2010
2Cachexia
01/2022 - 04/2006
2Pneumonia (Pneumonitis)
11/2020 - 11/2018
2Fanconi Anemia (Fanconi's Anemia)
01/2019 - 01/2016
2Disease Progression
05/2018 - 03/2010
2Brain Neoplasms (Brain Tumor)
02/2017 - 07/2016
2Anemia
10/2016 - 11/2010
2Dehydration (Water Stress)
10/2016 - 01/2010
2Vomiting
03/2016 - 11/2010
2Febrile Neutropenia
03/2016 - 11/2010
2Hemorrhage
05/2015 - 06/2012
2Sarcoma (Soft Tissue Sarcoma)
03/2014 - 02/2007
2Hematologic Neoplasms (Hematological Malignancy)
08/2011 - 08/2009
2Carcinogenesis
08/2009 - 11/2002
1Melanoma (Melanoma, Malignant)
01/2021
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2020
1Colitis
10/2019

Drug/Important Bio-Agent (IBA)

12Immune Checkpoint InhibitorsIBA
01/2022 - 03/2015
10NivolumabIBA
01/2022 - 03/2015
10DNA (Deoxyribonucleic Acid)IBA
01/2020 - 04/2003
9Docetaxel (Taxotere)FDA Link
10/2019 - 06/2002
8Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2012
7Carboplatin (JM8)FDA LinkGeneric
01/2019 - 08/2003
7ErbB Receptors (EGF Receptor)IBA
11/2018 - 09/2014
7Proteins (Proteins, Gene)FDA Link
11/2016 - 11/2004
6B7-H1 AntigenIBA
01/2022 - 11/2016
5IpilimumabIBA
01/2022 - 05/2018
5Tyrosine Kinase InhibitorsIBA
01/2019 - 12/2010
5Histone Deacetylase InhibitorsIBA
12/2017 - 05/2003
5Bevacizumab (Avastin)FDA Link
11/2016 - 12/2010
5Cisplatin (Platino)FDA LinkGeneric
05/2015 - 09/2004
5GemcitabineFDA Link
06/2013 - 09/2004
4PlatinumIBA
01/2018 - 04/2010
4Formaldehyde (Formol)FDA Link
09/2017 - 03/2013
4Paclitaxel (Taxol)FDA LinkGeneric
03/2016 - 08/2003
4SmokeIBA
09/2014 - 07/2009
4Capecitabine (Xeloda)FDA Link
01/2013 - 06/2002
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 05/2020
3Histones (Histone)IBA
01/2021 - 03/2006
3Messenger RNA (mRNA)IBA
01/2021 - 12/2013
3AntibodiesIBA
01/2020 - 03/2013
3CrizotinibIBA
01/2020 - 01/2013
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2017 - 05/2011
3Pemetrexed (MTA)FDA Link
11/2015 - 01/2013
3ParaffinIBA
05/2014 - 03/2013
3romidepsin (FK228)FDA Link
08/2011 - 05/2003
3Suramin (Suramin Sodium)IBA
11/2010 - 08/2003
3MicroRNAs (MicroRNA)IBA
07/2010 - 08/2009
2AlbuminsIBA
01/2022 - 11/2015
2pembrolizumabIBA
01/2021 - 01/2020
2130-nm albumin-bound paclitaxelIBA
01/2019 - 11/2015
2rociletinibIBA
11/2018 - 10/2016
2MethyltransferasesIBA
12/2017 - 05/2003
2VorinostatFDA Link
12/2017 - 05/2003
2Angiogenesis InhibitorsIBA
11/2016 - 12/2010
2Phosphotransferases (Kinase)IBA
11/2016 - 06/2003
2Alanine Transaminase (SGPT)IBA
10/2016 - 06/2012
2ElectrolytesIBA
03/2016 - 11/2010
2Etoposide (VP 16)FDA LinkGeneric
05/2015 - 06/2003
2Sunitinib (Sutent)FDA Link
05/2015 - 02/2014
23-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
06/2013 - 11/2012
2Dasatinib (BMS 354825)FDA Link
04/2012 - 03/2010
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2010 - 02/2007
2EnzymesIBA
11/2009 - 06/2002
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2006 - 11/2004
2Thymidine PhosphorylaseIBA
03/2005 - 06/2002
1Cell-Free Nucleic AcidsIBA
01/2021
1Untranslated RNA (Noncoding RNA)IBA
01/2021
1Temozolomide (Temodar)FDA LinkGeneric
01/2021
1LigandsIBA
12/2020
1Anti-Bacterial Agents (Antibiotics)IBA
05/2020
1LactamsIBA
05/2020
1AntigensIBA
01/2020
1Circulating Tumor DNAIBA
01/2020
1AgglutininsIBA
01/2020
1entrectinibIBA
01/2020
1Codon (Codons)IBA
11/2019
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019
1Biological ProductsIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
12/2017

Therapy/Procedure

32Therapeutics
01/2022 - 04/2006
18Drug Therapy (Chemotherapy)
01/2022 - 06/2002
7Immunotherapy
01/2022 - 01/2017
6Radiotherapy
11/2018 - 12/2014
1Aftercare (After-Treatment)
01/2020